Savara, Inc. (SVRA)
5.565
-0.02
(-0.45%)
USD |
NASDAQ |
Aug 24, 16:00
5.565
0.00 (0.00%)
After-Hours: 20:00
Savara Total Liabilities (Quarterly) : 48.48M for June 30, 2026
Total Liabilities (Quarterly) Chart
Sep '18
Jan '19
May '19
285.00
270.00
255.00
240.00
Historical Total Liabilities (Quarterly) Data
| Date | Value |
|---|---|
| June 30, 2026 | 48.48M |
| March 31, 2026 | 45.61M |
| December 31, 2025 | 50.30M |
| September 30, 2025 | 46.54M |
| June 30, 2025 | 43.28M |
| March 31, 2025 | 41.47M |
| December 31, 2024 | 41.43M |
| September 30, 2024 | 39.47M |
| June 30, 2024 | 37.94M |
| March 31, 2024 | 36.43M |
| December 31, 2023 | 37.19M |
| September 30, 2023 | 35.53M |
| June 30, 2023 | 32.12M |
| March 31, 2023 | 31.10M |
| December 31, 2022 | 32.00M |
| September 30, 2022 | 31.24M |
| June 30, 2022 | 29.74M |
| March 31, 2022 | 29.73M |
| December 31, 2021 | 32.10M |
| September 30, 2021 | 32.04M |
| June 30, 2021 | 31.05M |
| March 31, 2021 | 32.51M |
| December 31, 2020 | 33.36M |
| September 30, 2020 | 32.72M |
| June 30, 2020 | 31.35M |
| Date | Value |
|---|---|
| March 31, 2020 | 32.66M |
| December 31, 2019 | 34.50M |
| September 30, 2019 | 33.82M |
| June 30, 2019 | 34.53M |
| March 31, 2019 | 46.46M |
| December 31, 2018 | 47.16M |
| September 30, 2018 | 37.27M |
| June 30, 2018 | 35.23M |
| March 31, 2018 | 35.17M |
| December 31, 2017 | 40.78M |
| September 30, 2017 | 44.24M |
| June 30, 2017 | 46.00M |
| March 31, 2017 | 9.535M |
| December 31, 2016 | 21.21M |
| September 30, 2016 | 26.93M |
| June 30, 2016 | 31.25M |
| March 31, 2016 | 29.46M |
| December 31, 2015 | 30.33M |
| September 30, 2015 | 29.90M |
| June 30, 2015 | 14.23M |
| March 31, 2015 | 12.61M |
| December 31, 2014 | 11.84M |
| September 30, 2014 | 10.92M |
| June 30, 2014 | 9.149M |
| March 31, 2014 | 9.569M |
Total Liabilities Definition
Liabilities are a main portion of the balance sheet of a company that measure outstanding payables/obligations. A few examples of liabilties of a company include accounts payable, current debt, and capital lease obligations. From an accounting perspective, the balance sheet equation is Liabilties = Assets - Shareholder's Equity.
Total Liabilities (Quarterly) Range, Past 5 Years
--
Minimum
--
Maximum
--
Average
--
Median
Total Liabilities (Quarterly) Benchmarks
| Gilead Sciences, Inc. | 37.62B |
| Insmed, Inc. | 1.345B |
| United Therapeutics Corp. | 819.80M |
| Vertex Pharmaceuticals, Inc. | 7.175B |
| SELLAS Life Sciences Group, Inc. | 7.726M |
Total Liabilities (Quarterly) Related Metrics
| Total Assets (Quarterly) | 192.14M |
| Shareholders Equity (Quarterly) | 143.66M |
| Debt to Equity Ratio | 0.2117 |
| Current Ratio | 10.13 |
| Net Debt Paydown Yield | -0.01% |